| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 9.61e-06 | 1390 | 23 | 9 | GO:0045944 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.96e-04 | 269 | 23 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.51e-04 | 287 | 23 | 4 | GO:0035770 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 5.09e-04 | 1377 | 23 | 7 | GO:0140513 | |
| Pubmed | First case of B ALL with KMT2A-MAML2 rearrangement: a case report. | 4.18e-07 | 2 | 23 | 2 | 28535805 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 34550633 | ||
| Pubmed | Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells. | 1.25e-06 | 3 | 23 | 2 | 24166297 | |
| Pubmed | The super elongation complex (SEC) family in transcriptional control. | 2.51e-06 | 4 | 23 | 2 | 22895430 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 23399917 | ||
| Pubmed | The histone methyltransferase MLL1 permits the oscillation of circadian gene expression. | 4.18e-06 | 5 | 23 | 2 | 21113167 | |
| Pubmed | 6.06e-06 | 407 | 23 | 5 | 12693553 | ||
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 21896721 | ||
| Pubmed | SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. | 8.77e-06 | 7 | 23 | 2 | 19818711 | |
| Pubmed | Circular RNAs regulate neuron size and migration of midbrain dopamine neurons during development. | 1.17e-05 | 8 | 23 | 2 | 39117691 | |
| Pubmed | 1.66e-05 | 1327 | 23 | 7 | 32694731 | ||
| Pubmed | 1.88e-05 | 10 | 23 | 2 | 20153263 | ||
| Pubmed | CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. | 1.88e-05 | 10 | 23 | 2 | 22094252 | |
| Pubmed | 3.79e-05 | 14 | 23 | 2 | 20854876 | ||
| Pubmed | 6.36e-05 | 18 | 23 | 2 | 21030982 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 9.36e-05 | 134 | 23 | 3 | 25452129 | |
| Pubmed | 1.98e-04 | 847 | 23 | 5 | 35850772 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.13e-04 | 861 | 23 | 5 | 36931259 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 2.73e-04 | 908 | 23 | 5 | 19274049 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.94e-04 | 497 | 23 | 4 | 36774506 | |
| Pubmed | 3.54e-04 | 42 | 23 | 2 | 35705031 | ||
| Pubmed | Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. | 4.25e-04 | 46 | 23 | 2 | 8849451 | |
| Pubmed | 4.25e-04 | 46 | 23 | 2 | 25209997 | ||
| Pubmed | 4.87e-04 | 568 | 23 | 4 | 9110174 | ||
| Pubmed | A "double adaptor" method for improved shotgun library construction. | 5.07e-04 | 574 | 23 | 4 | 8619474 | |
| Pubmed | 6.53e-04 | 57 | 23 | 2 | 18022353 | ||
| Cytoband | 16q22.1 | 1.39e-03 | 110 | 23 | 2 | 16q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 3.78e-03 | 183 | 23 | 2 | chr16q22 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | 2.46e-05 | 1492 | 23 | 8 | M40023 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 2.55e-05 | 199 | 23 | 4 | M3417 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-06 | 190 | 23 | 4 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.02e-06 | 198 | 23 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.01e-05 | 157 | 23 | 3 | 1e3a4a7193d95f09d71c2dfe704b8e626c6d9624 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-05 | 169 | 23 | 3 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.00e-04 | 177 | 23 | 3 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.02e-04 | 178 | 23 | 3 | 44b5ba4e8788d3973749a1717e427647ac4c8579 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 184 | 23 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.18e-04 | 187 | 23 | 3 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.20e-04 | 188 | 23 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 189 | 23 | 3 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 189 | 23 | 3 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 190 | 23 | 3 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 190 | 23 | 3 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.27e-04 | 192 | 23 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 193 | 23 | 3 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-04 | 193 | 23 | 3 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-04 | 193 | 23 | 3 | e5016959f24370579a8770787e96869f264cf7b3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 194 | 23 | 3 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-04 | 196 | 23 | 3 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 197 | 23 | 3 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 197 | 23 | 3 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.37e-04 | 197 | 23 | 3 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 197 | 23 | 3 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 198 | 23 | 3 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 198 | 23 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.39e-04 | 198 | 23 | 3 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 198 | 23 | 3 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 198 | 23 | 3 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.44e-04 | 200 | 23 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.47e-05 | 49 | 13 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of CASP2 | 4.66e-04 | 27 | 13 | 2 | GCM_CASP2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Disease | anxiety disorder, stress-related disorder | 3.82e-05 | 12 | 23 | 2 | EFO_0006788, EFO_0010098 | |
| Disease | Neurodevelopmental Disorders | 5.13e-05 | 93 | 23 | 3 | C1535926 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.38e-04 | 346 | 23 | 4 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | unipolar depression, bipolar disorder | 2.38e-04 | 156 | 23 | 3 | EFO_0003761, MONDO_0004985 | |
| Disease | waist-hip ratio | 2.79e-04 | 1226 | 23 | 6 | EFO_0004343 | |
| Disease | alcohol consumption measurement | 2.99e-04 | 1242 | 23 | 6 | EFO_0007878 | |
| Disease | urate measurement, bone density | 1.24e-03 | 619 | 23 | 4 | EFO_0003923, EFO_0004531 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.32e-03 | 69 | 23 | 2 | DOID:1682 (implicated_via_orthology) | |
| Disease | alcoholic liver disease | 1.86e-03 | 82 | 23 | 2 | EFO_0008573 | |
| Disease | response to antineoplastic agent | 2.69e-03 | 99 | 23 | 2 | GO_0097327 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 2.80e-03 | 101 | 23 | 2 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | bipolar I disorder | 5.37e-03 | 141 | 23 | 2 | EFO_0009963 | |
| Disease | Bipolar Disorder | 5.85e-03 | 477 | 23 | 3 | C0005586 | |
| Disease | nasopharyngeal neoplasm | 6.13e-03 | 151 | 23 | 2 | EFO_0004252 | |
| Disease | creatinine measurement | 6.82e-03 | 995 | 23 | 4 | EFO_0004518 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IQQQQANSNSSTNTS | 606 | Q9H2F5 | |
| STNTSQNLASNQQKS | 616 | Q9H2F5 | |
| NTLQQNSSSNISYSN | 91 | O75077 | |
| RSTQQLQQQLNTSTQ | 2391 | Q6UB99 | |
| TNVESQNTNRNNSTA | 661 | Q96NI6 | |
| TQTTNTSNSTNKSQH | 501 | Q8NDF8 | |
| NSFSTTNNVCNQNQE | 496 | Q6ZWT7 | |
| QTNTTNASTSTNVAN | 2146 | Q2M2H8 | |
| NSTLNSQSTSLMNQN | 1111 | Q3V6T2 | |
| QQDQQNTQRLSSAQT | 261 | Q8TE12 | |
| QSTSNSEQQAAFQQQ | 1171 | O94916 | |
| QSSISAQQQQQQQSS | 621 | Q8IZL2 | |
| TANTTNTSFSASNNQ | 711 | Q08462 | |
| SVFQTNQSNNQQSNF | 1241 | Q6Y7W6 | |
| NLQQTTNTTSTQMTN | 296 | Q8NA54 | |
| IANTESSQQTLQNSQ | 276 | Q9P0J7 | |
| NNTSCQDSQSNNYQN | 2576 | Q03164 | |
| QQSTNQSRNPATTNQ | 351 | P50750 | |
| QLSSSNNNFQQTVSD | 211 | Q96BU1 | |
| NSQSFIQQCVQQTSS | 336 | Q92750 | |
| QTVSQQSQAQQSQND | 881 | Q9BQF6 | |
| SQQSNISSTQENLNS | 2351 | Q8NF91 | |
| QTLQSTSTQSQQNVL | 626 | O15516 | |
| FATQQQQSQTLSVTQ | 741 | O15516 | |
| QQQQQQQSSPSASTA | 126 | Q96EK4 |